Development of HER2-specific chimeric antigen receptor T cells for the treatment of breast-to-brain metastasis

Documenti analoghi

• Regional Delivery of Chimeric Antigen Receptor–Engineered T Cells Effectively Targets HER2(+) Breast Cancer Metastasis to the Brain
  di: Priceman, Saul J., et al.
  Pubblicazione: (2017)
• Development and optimization of PSCA-specific CAR T cells for the treatment of bone metastatic prostate cancer
  di: Gerdts, Ethan, et al.
  Pubblicazione: (2015)
• Development of chimeric antigen receptor (CAR) T-cell immunotherapy for glioblastoma targeting epidermal growth factor receptor variant III (EGFRvIII)
  di: Park, Anthony K, et al.
  Pubblicazione: (2015)
• PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with (89)Zr-Oxine
  di: Weist, Michael R., et al.
  Pubblicazione: (2018)
• Chimeric antigen receptors (CARs) incorporating mutations in the IgG4 Fc spacer region to eliminate Fc receptor recognition results in improved CAR T cell persistence and anti-tumor efficacy
  di: Jonnalagadda, Mahesh, et al.
  Pubblicazione: (2013)